← all drugs
Pentostatin Injection
in shortage · Oncology · Snapshot: 2026-10-09
Day 43
of this shortage, counting from the FDA's first posting on 08/27/2026
- Manufacturers listed
- Hospira, Inc., a Pfizer Company
- Reported reason(s)
- Other
- Machine-readable
- JSON for this drug
Presentations (1)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Nipent, Injection, 10 mg, single dose vial (NDC 0409-0801-01) | Hospira, Inc., a Pfizer Company | Unavailable | 08/27/2026 |
History
Daily tracking of this drug began 2026-08-28.
- 2026-08-28 — Pentostatin Injection appeared on the FDA shortage list (in shortage)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.